Melanoma

Showing NaN - NaN of 71

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

Recruiting
  • Colorectal Carcinoma
  • +21 more
  • Dual X-ray Absorptiometry
  • +2 more
  • Birmingham, Alabama
  • +18 more
Jan 30, 2023

Melanoma, NSCLC Trial in United States (brentuximab vedotin, pembrolizumab)

Recruiting
  • Melanoma
  • +2 more
  • Tucson, Arizona
  • +31 more
Jan 20, 2023

Small Cell Lung Cancer, NSCLC, Squamous, NSCLC, Non-squamous Trial in Worldwide (ladiratuzumab vedotin)

Recruiting
  • Small Cell Lung Cancer
  • +8 more
  • Chandler, Arizona
  • +65 more
Dec 19, 2022

Melanoma Trial in Worldwide (Relatlimab, Ipilimumab)

Active, not recruiting
  • Melanoma
  • Tucson, Arizona
  • +29 more
Dec 13, 2022

Melanoma Trial in Worldwide (Nivolumab, Nivolumab + Relatlimab Fixed Dose Combination)

Recruiting
  • Melanoma
  • Nivolumab
  • Nivolumab + Relatlimab Fixed Dose Combination
  • Birmingham, Alabama
  • +185 more
Dec 3, 2022

Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

Completed
  • Melanoma
  • +27 more
  • XmAb20717
  • Los Angeles, California
  • +16 more
Nov 29, 2022

Melanoma Trial in Worldwide (Talimogene Laherparepvec, Pembrolizumab, Placebo)

Terminated
  • Melanoma
  • Talimogene Laherparepvec
  • +2 more
  • Birmingham, Alabama
  • +160 more
Nov 10, 2022

Melanoma Trial in Worldwide (Pembrolizumab, Placebo)

Active, not recruiting
  • Melanoma
  • Pembrolizumab
  • Placebo
  • Tucson, Arizona
  • +158 more
Oct 31, 2022

Melanoma Trial in United States (TLPLDC, Placebo)

Completed
  • Melanoma
  • Birmingham, Alabama
  • +17 more
Sep 15, 2022

Melanoma, Ocular Melanoma Trial in United States (Nivolumab, Ipilimumab)

Active, not recruiting
  • Melanoma
  • Ocular Melanoma
  • San Francisco, California
  • +5 more
Aug 31, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Melanoma Trial in Australia, United States (mRNA-4157, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • mRNA-4157
  • Pembrolizumab
  • Tucson, Arizona
  • +21 more
Aug 23, 2022

Advanced Cancer, Melanoma, NSCLC Trial in Worldwide (BMS-986205, Nivolumab, Ipilimumab)

Completed
  • Advanced Cancer
  • +2 more
  • Tucson, Arizona
  • +46 more
Aug 18, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +24 more
Aug 1, 2022

Melanoma, NSCLC, Squamous Cell Carcinoma of Head and Neck Trial in United States (GEN-011, IL-2, Fludarabine)

Terminated
  • Melanoma
  • +8 more
  • GEN-011
  • +3 more
  • Gilbert, Arizona
  • +7 more
Jul 13, 2022

Melanoma Trial in Worldwide (Relatlimab, Nivolumab)

Active, not recruiting
  • Melanoma
  • Relatlimab
  • Nivolumab
  • Tucson, Arizona
  • +126 more
Mar 2, 2022

Melanoma, Carcinoma, Non-Small- Cell Lung Trial in Worldwide (SEA-CD40, pembrolizumab, pemetrexed)

Recruiting
  • Melanoma
  • Carcinoma, Non-Small- Cell Lung
  • Springdale, Arkansas
  • +18 more
Mar 11, 2022

Melanoma Trial in France, Germany, United States (Talimogene laherparepvec, Ipilimumab)

Completed
  • Melanoma
  • Tucson, Arizona
  • +39 more
Mar 9, 2022

Melanoma Trial in United States (MGA271)

Terminated
  • Melanoma
  • MGA271
  • Los Angeles, California
  • +6 more
Feb 4, 2022

Melanoma, Non Small Cell Lung Cancer Trial in United States (enoblituzumab plus ipilimumab)

Completed
  • Melanoma
  • Non Small Cell Lung Cancer
  • enoblituzumab plus ipilimumab
  • Los Angeles, California
  • +9 more
Feb 4, 2022

Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)

Completed
  • Prostate Cancer
  • +6 more
  • MGA271
  • Los Angeles, California
  • +11 more
Feb 4, 2022

Testing Practices for Common Solid Cancers in Precision Oncology

Active, not recruiting
  • Breast Carcinoma
  • +5 more
  • Survey Administration
  • Chicago, Illinois
    Center for Business Models in Healthcare
Dec 29, 2021

Melanoma Trial in Chicago (SSE educational intervention, Active control:Healthy Living)

Completed
  • Melanoma
  • SSE educational intervention
  • Active control:Healthy Living
  • Chicago, Illinois
    Northwestern University Feinberg School of Medicine Department o
Nov 19, 2021

Cutaneous Melanoma, Melanoma, Melanoma of Unknown Primary Trial in United States (DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly

Completed
  • Cutaneous Melanoma
  • +11 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +2 more
  • Chicago, Illinois
  • +6 more
Nov 10, 2021